Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Korean Medical Science ; : 514-520, 2008.
Artigo em Inglês | WPRIM | ID: wpr-201065

RESUMO

The understanding of main mechanisms that determine the ability of immune privilege related to Sertoli cells (SCs) will provide clues for promoting a local tolerogenic environment. In this study, we evaluated the property of humoral and cellular immune response modulation provided by porcine SCs. Porcine SCs were resistant to human antibody and complement-mediated formation of the membrane attack complex (38.41+/-2.77% vs. 55.02+/-5.44%, p=0.027) and cell lysis (42.95+/-1.75% vs. 87.99 +/-2.25%, p<0.001) compared to immortalized aortic endothelial cells, suggesting that porcine SCs are able to escape cellular lysis associated with complement activation by producing one or more immunoprotective factors that may be capable of inhibiting membrane attack complex formation. On the other hand, porcine SCs and their culture supernatant suppressed the up-regulation of CD40 expression (p<0.05) on DCs in the presence of LPS stimulation. These novel findings, as we know, suggest that immune modulatory effects of porcine SCs in the presence of other antigen can be obtained from the first step of antigen presentation. These might open optimistic perspectives for the use of porcine SCs in tolerance induction eliminating the need for chronic immunosuppressive drugs.


Assuntos
Animais , Humanos , Masculino , Camundongos , Anticorpos Heterófilos/imunologia , Formação de Anticorpos/imunologia , Antígenos CD40/imunologia , Aorta/citologia , Linhagem Celular Transformada , Sobrevivência Celular/imunologia , Complexo de Ataque à Membrana do Sistema Complemento/imunologia , Proteínas do Sistema Complemento/imunologia , Células Dendríticas/citologia , Células Endoteliais/citologia , Epitopos/imunologia , Tolerância Imunológica/imunologia , Imunidade Celular/imunologia , Camundongos Endogâmicos C57BL , Células de Sertoli/citologia , Suínos , Engenharia Tecidual , Transplante Heterólogo
2.
In. Palomo González, Iván; Ferreira Vigoroux, Arturo; Sepúlveda Carvajal, Cecilia; Rosemblatt Silber, Mario; Vergara Castillo, Ulises. Fundamentos de inmunología. Talca, Universidad de Talca, 1998. p.319-49, ilus, tab.
Monografia em Espanhol | LILACS | ID: lil-284814
3.
Arch. argent. alerg. inmunol. clín ; 29(4): 29-48, 1998. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-235084

RESUMO

A un siglo de su descubrimiento por Bordet, se trata de poner un poco de orden en los mecanismos de activación del complemento a través de su hasta ahora conocidas rutas de activación clásica o de C1 y la vía alterna o de la properdina. Se hace además referencia a otras vías de activación descritas más recientemente como la activación iniciada por la lectina de unión a la manosa (MBL). Se destaca también la actividad de los componentes inhibidores o controladores, que frenan la actividad del sistema, evitando la producción de daños por la formación y liberación de péptidos con potente acción biológica derivados del mismo, tal el caso de las anafilatoxinas. Se hace además referencia a la presencia de receptores para el complemento, ubicados en la membrana de diversas células del sistema inmunológico, responsables de muchas de las principales actividades del sistema, como la fagocitosis de microorganismos a través de la unión de receptores para C3b (principal opsonina) sobre la membrana de las células fagocitarias


Assuntos
Humanos , Proteínas do Sistema Complemento/fisiologia , Programas de Autoavaliação , Ativação do Complemento/imunologia , Inativadores do Complemento/imunologia , Complexo de Ataque à Membrana do Sistema Complemento/imunologia , Proteínas do Sistema Complemento/imunologia , Receptores de Complemento/imunologia , Via Alternativa do Complemento/imunologia , Via Clássica do Complemento/imunologia
4.
Ciênc. cult. (Säo Paulo) ; 46(5/6): 433-40, Sept.-Dec. 1994. ilus
Artigo em Inglês | LILACS | ID: lil-199876

RESUMO

Schistosoma mansoni is a trematode that parasitizes man and other mammals, surviving in the vertebrate host for decades, despite eliciting a strong cellular and humoral immune response. The mechanism by which S. mansoni evades immune attack, even in the presence of specific antischistosome antibodies and complement has been the object of perplexity. It was originally proposed that schistosomes avoid antibody recognition by masking themselves with host antigens, and erythrocyte-derived molecules have been appointed as playing this role. We have discovered that schistosomula become complement-resistant by incorporating into their surface a complement inhibitory molecule released from human erythrocytes (HuE). This molecule was shown to be the decay-accelerating factor (DAF), a 70 kDa protein tethered to the surface of HuE by a glycosylphosphatidylinositol (GPI) anchor. The mechanism by which schistosomula acquire DAF from the surface of HuE and its importance to the survival of S.mansoni in the host are discussed.


Assuntos
Animais , /imunologia , Proteínas do Sistema Complemento/imunologia , Sistema Imunitário/imunologia , Schistosoma mansoni/imunologia , Complexo de Ataque à Membrana do Sistema Complemento/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA